ONETTO NICOLE
Transaction: 06/10/2026
BUY
Change
+5,000
Price
$4.43
Filing
06/11/2026
Type
BUY
Bolt Biotherapeutics, Inc.
BOLT • Biotechnology
$3.90
▲ +0.00 (+0.13%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$6.59M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 232.4%Manageable debt level · 0.87Healthy liquidity · 3.59Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 1:11 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$3.90
Change0.13%
Shares Out1.69M
Market Cap$6.59M
Enterprise Value$10.62M
52W Range3.13 - 7.20
Beta1.08
P/E-0.23
P/S1.40
P/B0.52
P/FCF-0.21
EV/Sales2.26
Price$3.90
Change0.13%
Shares Out1.69M
Market Cap$6.59M
Enterprise Value$10.62M
52W Range3.13 - 7.20
Beta1.08
P/E-0.23
P/S1.40
P/B0.52
P/FCF-0.21
EV/Sales2.26
EV/EBITDA-0.37
EV/FCF-0.34
Earnings Yield-435.90%
FCF Yield-478.32%
Dividend Yield0.00%
Gross Margin80.62%
Oper. Margin-4.50%
Profit Margin-4.34%
Debt/Eq0.87
Current Ratio3.59
Quick Ratio3.59
Target$4.00
Target Upside2.56%
Target Median$4.00
Target Range1.00 - 7.00
Volume28.21K
Avg Volume25.25K
EPS Surprise-1.46
Investment DNA
How strong this company looks for long-term investors
55
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
94/100
Why this score▼
Positive revenue growth · 232.4%Manageable debt level · 0.87Healthy liquidity · 3.59Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 8 analyst votes · 2026-09-05
69/100
Neutral
Bullish
3
Hold
5
Bearish
0
Price Target
2026-08-14
Low
$1.00
Mean
$4.00
Median
$4.00
High
$7.00
Insider Transactions
Recent executive and insider activity
O'CALLAGHAN BRIAN
Transaction: 06/10/2026
BUY
Change
+5,000
Price
$4.43
Filing
06/11/2026
Type
BUY
Dupont Jakob
Transaction: 06/10/2026
BUY
Change
+5,000
Price
$4.43
Filing
06/11/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| ONETTO NICOLE | BUY | +5,000 | $4.43 | 06/10/2026 | 06/11/2026 |
| O'CALLAGHAN BRIAN | BUY | +5,000 | $4.43 | 06/10/2026 | 06/11/2026 |
| Dupont Jakob | BUY | +5,000 | $4.43 | 06/10/2026 | 06/11/2026 |
| LAPORTE KATHLEEN | BUY | +5,000 | $4.43 | 06/10/2026 | 06/11/2026 |
| Berner Laura | BUY | +5,000 | $4.43 | 06/10/2026 | 06/11/2026 |
| Nemec Sarah | BUY | +8,000 | $6.71 | 01/28/2026 | 02/04/2026 |
| Yonehiro Grant | BUY | +10,000 | $6.71 | 01/28/2026 | 02/04/2026 |
| Quinn William P. | BUY | +20,000 | $6.71 | 01/28/2026 | 02/04/2026 |
| Nemec Sarah | BUY | +125 | $4.61 | 12/05/2025 | 02/04/2026 |
| Quinn William P. | BUY | +125 | $4.61 | 12/05/2025 | 02/04/2026 |
| Quinn William P. | SELL | -11,749 | $25.40 | 12/12/2025 | 12/16/2025 |
| Yonehiro Grant | SELL | -7,749 | $14.60 | 12/12/2025 | 12/16/2025 |
| Nemec Sarah | SELL | -2,199 | $61.60 | 12/12/2025 | 12/16/2025 |
| O'CALLAGHAN BRIAN | SELL | -1,100 | $15.36 | 12/12/2025 | 12/16/2025 |
| LAPORTE KATHLEEN | SELL | -1,250 | $32.60 | 12/12/2025 | 12/16/2025 |
| Berner Laura | SELL | -1,250 | $32.60 | 12/12/2025 | 12/16/2025 |
| ONETTO NICOLE | SELL | -1,100 | $6.40 | 12/12/2025 | 12/16/2025 |
| ONETTO NICOLE | SELL | -1,250 | $39.80 | 12/12/2025 | 12/16/2025 |
| Dupont Jakob | SELL | -1,100 | $6.40 | 12/12/2025 | 12/16/2025 |
| Quinn William P. | BUY | +40,000 | Not reported | 10/22/2025 | 10/24/2025 |